This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study design
This was a cohort study that was undertaken in a single institution. It was unclear whether the study was conducted prospectively or retrospectively. The mean duration of follow-up was 3.5 months (Range: 1 to 9) for the coil group and 2.4 months (Range: 1 to 7) for the AVP group, (p=0.508) . No loss to follow-up was reported. No blinded assessment was reported.
Analysis of effectiveness
All of the patients included in the study were accounted for in the analysis. The primary health outcomes used were duration of the procedure and complication rates. At analysis, the groups were shown to be comparable in terms of their age and primary aneurismal issues.
Effectiveness results
The mean duration of the procedure was 11 days (Range: 7 to 30) for the coil group and 19 days (Range: 0 to 78) for the AVP group.
The numbers (rate) of detected complications in the coil and AVP groups, respectively, were: 3 (30%) and 2 (40%) for buttock claudication, (p=1.000); 0 (0%) and 1 (20%) for endoleak, (p=0.333); 0 (0%) and 1 (20%) for groin haematoma, (p=0.333); 3 (30%) and 0 (0%) for 2nd coiling requirement, (p=0.505); and 2 (20%) and 0 (0%) for device dislodging, (p=0.524).
Clinical conclusions
The AVP allowed reliable occlusion of the IIA in patients undergoing endograft repair for aortoiliac aneurysms. The use of AVP with a precise placement at the origin of the artery avoided significant complications.
Measure of benefits used in the economic analysis
No summary benefit measure was derived and only separate clinical outcomes were reported. As such, a costconsequences analysis was performed.
Direct costs
The quantity/cost boundary adopted appears to have been that of the hospital. Only the costs of the coils and AVPs were included in the economic analysis. The quantities and the costs were reported separately. The estimation of the quantities and costs was based on actual data. Discounting was not conducted. The price year was not reported.
Statistical analysis of costs
The costs and resource use were treated stochastically. The number of devices used per IIA and costs were compared using the independent samples t-test, with significance set at the 0.05 level.
Indirect Costs
The indirect costs were not included in the analysis.
Currency

US dollars ($).
Sensitivity analysis
No sensitivity analysis was performed.
Estimated benefits used in the economic analysis
See the 'Effectiveness Results' section.
Cost results
The average total cost per IIA was $3,500 for coils and $375 for the AVP.
Synthesis of costs and benefits
The costs and benefits were not combined.
Authors' conclusions
The Amplatzer Vascular Plug (AVP) was a cost-effective alternative to occlude the internal iliac artery (IIA) in patients undergoing endograft repairs of aortoiliac aneurysms.
CRD COMMENTARY -Selection of comparators
The rationale for the choice of the comparators was clear since the use of coils represented traditional practice. You should verify whether this health technology is relevant to your own setting.
Validity of estimate of measure of effectiveness
The basis of the analysis was a cohort study, which was appropriate for the study design. The patient groups were shown to have been comparable in terms of their age and primary aneurismal issues. However, since no power calculations were reported and the study sample was very small, the study might have lacked sufficient power to detect all differences in baseline characteristics or clinical outcomes between the two groups. In addition, blinding of the outcome assessment was not reported. These factors may introduce potential bias. Nevertheless, several strengths of the analysis should be pointed out. First, the inclusion criteria used in the study were reported. Second, appropriate statistical analyses were undertaken to test for statistically significant differences between the two study groups. Finally, all of the patients included in the study were accounted for in the analysis.
Validity of estimate of measure of benefit
The authors did not derive a summary measure of health benefit. The analysis was therefore categorised as a costconsequences study. This approach is more informative and appropriate for the interventions considered.
Validity of estimate of costs
The perspective adopted in the economic analysis was not reported, but it appears to have been that of the hospital. Only the costs of coils and the AVPs were included; other relevant costs were not taken into consideration. The authors acknowledged that taking the operating time and labour costs into account would have increase the savings with AVPs. Therefore, such omissions were unlikely to have affected the authors' conclusions. The costs and the quantities were
